Stockscreener 앱 받기
3.195
1.26%
0.025
Oramed Pharmaceuticals Inc 주식(ORMP)의 최신 뉴스
Aug Outlook: How much upside does Bakkt Holdings Inc Equity Warrant haveRecession Risk & Growth Focused Stock Pick Reports - baoquankhu1.vn
NNDM stock in focus: Nano Dimension pops a poison pill days after Oramed stake build-up - MSN
Oramed Pharmaceuticals (NASDAQ:ORMP) & Demant A/S (OTCMKTS:WILYY) Head to Head Analysis - Defense World
Pullback Watch: Is Oramed Pharmaceuticals Inc stock a smart retirement pickQuarterly Profit Report & Daily Technical Forecast Reports - baoquankhu1.vn
What is the next catalyst for Oramed Pharmaceuticals Inc.July 2025 Sentiment & Stock Portfolio Risk Control - mfd.ru
Swing Trade: What is Oramed Pharmaceuticals Incs 5 year growth outlookJuly 2025 Market Mood & Breakout Confirmation Trade Signals - baoquankhu1.vn
Oramed Pharmaceuticals Achieves 60.85% Return, Leading Market Performance - Markets Mojo
OraTech to pioneer oral insulin with $75 million investment - MSN
Oramed Pharm completes warrant sale, boosting liquidity - MSN
NNDM Stock In Focus: Nano Dimension Pops A Poison Pill Days After Oramed Stake Build-Up - Stocktwits
Aug Update: What is ReTo Eco Solutions Incs book value per shareJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Is Oramed Pharmaceuticals Inc. stock a smart retirement pickJuly 2025 Short Interest & Trade Opportunity Analysis Reports - mfd.ru
Portfolio Recap: Should I set a stop loss on SDOWJuly 2025 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Jobs Data: Is Oramed Pharmaceuticals Inc stock good for income investors2025 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Oramed Shares Face Pressure Amid Strategic Pivot and Dividend Focus - AD HOC NEWS
Is Oramed Pharmaceuticals Inc. stock undervalued right nowVolume Analysis Techniques & Plan Every Trade With Controlled Risk - bollywoodhelpline.com
What hedge funds are buying Oramed Pharmaceuticals Inc.Recession Risk & Daily Technical Forecast Reports - bollywoodhelpline.com
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Sees Large Increase in Short Interest - MarketBeat
Published on: 2026-01-17 10:34:33 - baoquankhu1.vn
Oramed Pharmaceuticals Inc.: - marketscreener.com
Oramed Pharm pivots with Lifeward strategic platform deal - TipRanks
Oramed Pharmaceuticals Signs Multiple Material Agreements - TradingView — Track All Markets
3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st
Oramed to transfer oral drug delivery platform to Lifeward By Investing.com - Investing.com Nigeria
Lifeward to acquire Oramed’s oral protein delivery tech in $47 million deal - Investing.com Nigeria
Lifeward Forms Strategic Partnership and Financing Deal with Oramed - The Globe and Mail
Buyout Rumor: Can Oramed Pharmaceuticals Inc maintain sales growthQuarterly Investment Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Oramed And Lifeward Reveal Strategic Deal - Pulse 2.0
Oramed to transfer oral drug delivery platform to Lifeward - Investing.com India
Lifeward to acquire Oramed’s oral protein delivery tech in $47 million deal By Investing.com - Investing.com South Africa
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company - manilatimes.net
Oramed and Lifeward Announce Strategic Transaction - Financial Times
Lifeward Ltd. announced that it expects to receive $20 million in funding from Oramed Pharmaceuticals Inc. - marketscreener.com
Oramed Announces Shareholder Capital Return Following Strategic Windfall - AD HOC NEWS
Take Profit: Will Oramed Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Intraday Action & Growth Focused Investment Plans - Улправда
Why Oramed Pharmaceuticals Inc. stock could outperform in 2025Trade Performance Summary & Risk Managed Investment Entry Signals - Улправда
Is Oramed Pharmaceuticals Inc. stock a buy in volatile markets2025 Retail Activity & Daily Volume Surge Signals - ulpravda.ru
Will Oramed Pharmaceuticals Inc. stock outperform value stocks2025 Key Lessons & Intraday High Probability Alerts - ulpravda.ru
Oramed Pharmaceuticals Inc. Declares Dividend of $0.25 (NASDAQ:ORMP) - MarketBeat
Oramed inks deal with Medicox for oral insulin in South Korea - The Pharma Letter
Is Oramed Pharmaceuticals Inc. (OJU1) stock suitable for passive index fundsMarket Sentiment Shifts & Outstanding Capital Returns - Улправда
MSN Money - MSN
Oramed Pharmaceuticals Inc. Approves Cash Dividend Payable on January 26, 2026 - MarketScreener
Oramed stock rises after receiving $18 million payment from Scilex By Investing.com - Investing.com Nigeria
Oramed receives $18 million payment from Scilex, declares dividend By Investing.com - Investing.com Nigeria
Oramed Pharm Announces Dividend After Scilex Payment Gain - TipRanks
Oramed receives $18 million payment from Scilex, declares dividend - Investing.com
Oramed Pharmaceuticals Inc Receives $18 Million Payment and Approves Dividend - TradingView
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments - Barchart.com
0.66%
자본화:
|
볼륨(24시간):